319 related articles for article (PubMed ID: 26060798)
61. Hypertensive retinopathy and cerebral small vessel disease in Amerindians living in rural Ecuador: The Atahualpa Project.
Del Brutto OH; Mera RM; Viteri EM; Pólit J; Ledesma EA; Cano JA; Plaza KJ; Zambrano M; Costa AF
Int J Cardiol; 2016 Sep; 218():65-68. PubMed ID: 27232913
[TBL] [Abstract][Full Text] [Related]
62. Dotlike hemosiderin spots are associated with past hemorrhagic strokes in patients with lacunar infarcts.
Imaizumi T; Honma T; Horita Y; Iihoshi S; Nomura T; Yoshifuji K; Niwa J
J Neuroimaging; 2005 Apr; 15(2):157-63. PubMed ID: 15746228
[TBL] [Abstract][Full Text] [Related]
63. Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL.
Liem MK; van der Grond J; Haan J; van den Boom R; Ferrari MD; Knaap YM; Breuning MH; van Buchem MA; Middelkoop HA; Lesnik Oberstein SA
Stroke; 2007 Mar; 38(3):923-8. PubMed ID: 17272761
[TBL] [Abstract][Full Text] [Related]
64. White matter hyperintensities and recurrent stroke risk in patients with stroke with small-vessel disease.
Park JH; Heo SH; Lee MH; Kwon HS; Kwon SU; Lee JS;
Eur J Neurol; 2019 Jun; 26(6):911-918. PubMed ID: 30637882
[TBL] [Abstract][Full Text] [Related]
65. Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease.
Wiseman SJ; Doubal FN; Chappell FM; Valdés-Hernández MC; Wang X; Rumley A; Lowe GD; Dennis MS; Wardlaw JM
Cerebrovasc Dis; 2015; 40(3-4):157-64. PubMed ID: 26279056
[TBL] [Abstract][Full Text] [Related]
66. Cerebral microbleeds and white matter hyperintensities in cardioembolic stroke patients due to atrial fibrillation: single-centre longitudinal study.
Charidimou A; Inamura S; Nomura T; Kanno A; Kim SN; Imaizumi T
J Neurol Sci; 2016 Oct; 369():263-267. PubMed ID: 27653903
[TBL] [Abstract][Full Text] [Related]
67. Relationship Between White Matter Hyperintensities Penumbra and Cavity Formation.
Zhang X; Ding L; Yang L; Qin W; Li Y; Li S; Hu W
Med Sci Monit; 2016 Jan; 22():41-9. PubMed ID: 26729408
[TBL] [Abstract][Full Text] [Related]
68. [Lacunar infarcts].
Norrving B
Ther Umsch; 2003 Sep; 60(9):535-40. PubMed ID: 14579622
[TBL] [Abstract][Full Text] [Related]
69. Cerebral microbleeds: a review.
Loitfelder M; Seiler S; Schwingenschuh P; Schmidt R
Panminerva Med; 2012 Sep; 54(3):149-60. PubMed ID: 22801432
[TBL] [Abstract][Full Text] [Related]
70. Progression of White Matter Hyperintensities Contributes to Lacunar Infarction.
Xu X; Gao Y; Liu R; Qian L; Chen Y; Wang X; Xu Y
Aging Dis; 2018 Jun; 9(3):444-452. PubMed ID: 29896432
[TBL] [Abstract][Full Text] [Related]
71. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.
van der Veen PH; Muller M; Vincken KL; Hendrikse J; Mali WP; van der Graaf Y; Geerlings MI;
Stroke; 2015 May; 46(5):1233-8. PubMed ID: 25804924
[TBL] [Abstract][Full Text] [Related]
72. [White Matter Lesion and Alzheimer's Disease: The Association between Small Vessel Disease and Neuropsychiatric Symptoms in Alzheimer's Disease].
Hashimoto M; Ikeda M
Brain Nerve; 2015 Apr; 67(4):427-32. PubMed ID: 25846591
[TBL] [Abstract][Full Text] [Related]
73. Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study.
Wang N; Allali G; Kesavadas C; Noone ML; Pradeep VG; Blumen HM; Verghese J
J Alzheimers Dis; 2016; 50(3):699-707. PubMed ID: 26757037
[TBL] [Abstract][Full Text] [Related]
74. Neuroimaging signatures of cerebral small vessel disease and risk of falls in stroke-free older adults living in rural Ecuador. The Atahualpa Project.
Del Brutto OH; Peinado CD; Mera RM; Del Brutto VJ; Sedler MJ
J Neurol Sci; 2019 Jul; 402():133-135. PubMed ID: 31132535
[TBL] [Abstract][Full Text] [Related]
75. Basilar Artery Dolichoectasia: Prevalence and Correlates With Markers of Cerebral Small Vessel Disease in Community-Dwelling Older Adults.
Del Brutto OH; Mera RM; Del Brutto VJ; Costa AF; Zambrano M; Brorson J
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2909-2914. PubMed ID: 28869136
[TBL] [Abstract][Full Text] [Related]
76. Poor sleep quality and silent markers of cerebral small vessel disease: a population-based study in community-dwelling older adults (The Atahualpa Project).
Del Brutto OH; Mera RM; Zambrano M; Lama J; Del Brutto VJ; Castillo PR
Sleep Med; 2015 Mar; 16(3):428-31. PubMed ID: 25681211
[TBL] [Abstract][Full Text] [Related]
77. Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial.
Blair GW; Appleton JP; Flaherty K; Doubal F; Sprigg N; Dooley R; Richardson C; Hamilton I; Law ZK; Shi Y; Stringer MS; Thrippleton MJ; Boyd J; Shuler K; Bath PM; Wardlaw JM
EClinicalMedicine; 2019; 11():34-43. PubMed ID: 31317131
[TBL] [Abstract][Full Text] [Related]
78. Updates on Prevention of Hemorrhagic and Lacunar Strokes.
Tsai HH; Kim JS; Jouvent E; Gurol ME
J Stroke; 2018 May; 20(2):167-179. PubMed ID: 29886717
[TBL] [Abstract][Full Text] [Related]
79. Potential recruitment into a clinical trial of vascular secondary prevention medications in cerebral small vessel disease, based on concomitant medication use.
Morrison E; Lyall DM; Pell JP; Mackay DF; Doubal FN; Wardlaw JM; Quinn T; Makin S
Cereb Circ Cogn Behav; 2021; 2():100015. PubMed ID: 36324721
[TBL] [Abstract][Full Text] [Related]
80. Small-vessel disease in the brain.
Singh A; Bonnell G; De Prey J; Buchwald N; Eskander K; Kincaid KJ; Wilson CA
Am Heart J Plus; 2023 Mar; 27():100277. PubMed ID: 38511094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
